Prenumeration
Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on March 24, 2025, that the Company is launching NOSA Nozoil Original and NOSA Nozoil Menthol, a moisturizing nasal spray designed for individuals with dry nasal mucosa, on the German pharmacy market. The launch is taking place in collaboration with the three largest pharmaceutical wholesalers in Germany: Alliance, Noweda, and Pharma Privat.
In summary, Analyst Group considers the launch of NOSA Nozoil in the German pharmacy market to be a significant step in the Company’s growth journey. The already established and extensive distribution network allows for efficient scaling of sales. Furthermore, Analyst Group sees the launch as a key initiative to strengthen the Nosa Plugs brand and position the Company as a more relevant player in the nasal health segment—an explicit strategic direction from Nosa Plugs, which is also expected to drive sales of other consumer products in Germany.
Read Analyst Group’s comment here (ENG & SWE)
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.